BR0208829A - Sal farmaceuticamente aceitável, composto, processos para a preparação de um sal, de um composto e de uma forma cristalina dos compostos, formulação farmacêutica, uso de um composto, e, método de profilaxia ou tratamento de uma arritmia - Google Patents
Sal farmaceuticamente aceitável, composto, processos para a preparação de um sal, de um composto e de uma forma cristalina dos compostos, formulação farmacêutica, uso de um composto, e, método de profilaxia ou tratamento de uma arritmiaInfo
- Publication number
- BR0208829A BR0208829A BR0208829-0A BR0208829A BR0208829A BR 0208829 A BR0208829 A BR 0208829A BR 0208829 A BR0208829 A BR 0208829A BR 0208829 A BR0208829 A BR 0208829A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- salt
- pharmaceutically acceptable
- treatment
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"SAL FARMACEUTICAMENTE ACEITáVEL, COMPOSTO, PROCESSOS PARA A PREPARAçãO DE UM SAL, DE UM COMPOSTO E DE UMA FORMA CRISTALINA DOS COMPOSTOS, FORMULAçãO FARMACêUTICA USO DE UM COMPOSTO, E, MéTODO DE PROFILAXIA OU TRATAMENTO DE UMA ARRITMIA". São fornecidas formas substancialmente cristalinas de, 4-([3-{7-(3,3-dimetil-2-oxobutil)-9-oxa-3,7-diazabiciclo[3,3,1]non-3-il]- propil} amino)benzonitrila, 2-{7- [3-(4-cianoanilino)propil]-9-oxa-3,7diazabiciclo[3,3,1]non-3-il}etilcarb amato de terc-butila, 2-{7-[4-(4-cianofenil)butil]-9-oxa-3,7-diazabiciclo[3,3,1]non-3-il}etilcar bamato de tercbutila ou 2-{7-[(2S)-3-(4-cianofenóxi)-2-hidroxipropil]-9-oxa-3,7-diazabiciclo[3, 3,1]non-3-il}etilcarbamato de terc-butila e seus sais farmaceuticamente aceitáveis, cujos compostos são úteis no tratamento de arritmias cardíacas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101327A SE0101327D0 (sv) | 2001-04-12 | 2001-04-12 | New crystalline forms |
| PCT/SE2002/000725 WO2002083688A1 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0208829A true BR0208829A (pt) | 2004-03-09 |
Family
ID=20283783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0208829-0A BR0208829A (pt) | 2001-04-12 | 2002-04-12 | Sal farmaceuticamente aceitável, composto, processos para a preparação de um sal, de um composto e de uma forma cristalina dos compostos, formulação farmacêutica, uso de um composto, e, método de profilaxia ou tratamento de uma arritmia |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7217708B2 (pt) |
| EP (2) | EP1389213B1 (pt) |
| JP (1) | JP2004525970A (pt) |
| KR (1) | KR20030087078A (pt) |
| CN (1) | CN1269823C (pt) |
| AR (1) | AR035452A1 (pt) |
| AT (1) | ATE323095T1 (pt) |
| BR (1) | BR0208829A (pt) |
| CA (1) | CA2443470A1 (pt) |
| CZ (1) | CZ20032760A3 (pt) |
| DE (1) | DE60210598T2 (pt) |
| DK (1) | DK1389213T3 (pt) |
| EE (1) | EE200300504A (pt) |
| ES (1) | ES2261721T3 (pt) |
| HK (1) | HK1061026A1 (pt) |
| HU (1) | HUP0303487A3 (pt) |
| IL (1) | IL158250A0 (pt) |
| IS (1) | IS6980A (pt) |
| MX (1) | MXPA03009206A (pt) |
| NO (1) | NO20034527L (pt) |
| NZ (1) | NZ528560A (pt) |
| PL (1) | PL367179A1 (pt) |
| PT (1) | PT1389213E (pt) |
| RU (1) | RU2286993C2 (pt) |
| SE (1) | SE0101327D0 (pt) |
| SK (1) | SK12572003A3 (pt) |
| TW (1) | TWI237025B (pt) |
| UA (1) | UA74629C2 (pt) |
| WO (1) | WO2002083688A1 (pt) |
| ZA (1) | ZA200307759B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI259836B (en) * | 2001-04-12 | 2006-08-11 | Astrazeneca Ab | Modified release formulation suitable for antiarrhythmic compounds |
| SE0401539D0 (sv) * | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
| SE0401540D0 (sv) * | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
| CN101243093A (zh) * | 2005-06-13 | 2008-08-13 | 阿斯利康(瑞典)有限公司 | 用于治疗心律不齐的新型氧杂双哌啶化合物 |
| AU2006259937A1 (en) * | 2005-06-20 | 2006-12-28 | Astrazeneca Ab | Process for the preparation of N,N'- disubstituted oxabispidines |
| AR053901A1 (es) * | 2005-06-20 | 2007-05-23 | Astrazeneca Ab | Formas fisicas de oxabispidinas n,n'- disustituidas |
| TW200734342A (en) * | 2005-12-15 | 2007-09-16 | Astrazeneca Ab | New compounds for the treatment of cardiac arrhythmias |
| EP2001881A2 (en) * | 2006-03-07 | 2008-12-17 | Endacea, Inc. | Compositions and methods for treating respiratory disorders |
| KR101130592B1 (ko) | 2006-06-26 | 2012-04-02 | 워너 칠콧 컴퍼니 엘엘씨 | 프롤릴 히드록실라제 저해제 및 사용 방법 |
| NO2686520T3 (pt) | 2011-06-06 | 2018-03-17 | ||
| EP2717870B1 (en) | 2011-06-06 | 2017-09-27 | Akebia Therapeutics Inc. | Composition for stabilizing hypoxia inducible factor-2 alpha useful for treating cancer |
| NZ753904A (en) | 2013-06-13 | 2020-07-31 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
| RU2021125455A (ru) | 2013-11-15 | 2021-10-05 | Экебиа Терапьютикс, Инк. | Твердые формы { [5-(3-хлорфенил)-3-гидроксипиридин-2-карбонил]амино} уксусной кислоты, их композиции и применения |
| EP3247355A4 (en) | 2015-01-23 | 2018-06-13 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
| LT3277270T (lt) | 2015-04-01 | 2022-01-10 | Akebia Therapeutics, Inc. | Kompozicijos ir būdai skirti anemijos gydymui |
| MX2020011845A (es) | 2018-05-09 | 2021-01-15 | Akebia Therapeutics Inc | Proceso para preparar acido 2-[[5-(3-clorofenil)-3-hidroxipiridina -2-carbonil]amino]acetico. |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3732094A1 (de) * | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
| US5110933A (en) | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
| SE9704709D0 (sv) | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
| SE9902268D0 (sv) | 1999-06-16 | 1999-06-16 | Astra Ab | Pharmaceutically active compounds |
| SE9903759D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
-
2001
- 2001-04-12 SE SE0101327A patent/SE0101327D0/xx unknown
-
2002
- 2002-04-01 TW TW091106493A patent/TWI237025B/zh not_active IP Right Cessation
- 2002-04-02 AR ARP020101189A patent/AR035452A1/es not_active Application Discontinuation
- 2002-04-12 AT AT02761972T patent/ATE323095T1/de not_active IP Right Cessation
- 2002-04-12 WO PCT/SE2002/000725 patent/WO2002083688A1/en active IP Right Grant
- 2002-04-12 RU RU2003129231/04A patent/RU2286993C2/ru not_active IP Right Cessation
- 2002-04-12 EP EP02761972A patent/EP1389213B1/en not_active Expired - Lifetime
- 2002-04-12 HU HU0303487A patent/HUP0303487A3/hu unknown
- 2002-04-12 IL IL15825002A patent/IL158250A0/xx unknown
- 2002-04-12 KR KR10-2003-7013320A patent/KR20030087078A/ko not_active Application Discontinuation
- 2002-04-12 CN CNB028116283A patent/CN1269823C/zh not_active Expired - Fee Related
- 2002-04-12 MX MXPA03009206A patent/MXPA03009206A/es active IP Right Grant
- 2002-04-12 EP EP05007851A patent/EP1550663A1/en not_active Withdrawn
- 2002-04-12 ES ES02761972T patent/ES2261721T3/es not_active Expired - Lifetime
- 2002-04-12 SK SK1257-2003A patent/SK12572003A3/sk not_active Application Discontinuation
- 2002-04-12 PL PL02367179A patent/PL367179A1/xx unknown
- 2002-04-12 JP JP2002581443A patent/JP2004525970A/ja active Pending
- 2002-04-12 BR BR0208829-0A patent/BR0208829A/pt not_active IP Right Cessation
- 2002-04-12 EE EEP200300504A patent/EE200300504A/xx unknown
- 2002-04-12 NZ NZ528560A patent/NZ528560A/en unknown
- 2002-04-12 CZ CZ20032760A patent/CZ20032760A3/cs unknown
- 2002-04-12 PT PT02761972T patent/PT1389213E/pt unknown
- 2002-04-12 US US10/474,592 patent/US7217708B2/en not_active Expired - Fee Related
- 2002-04-12 DK DK02761972T patent/DK1389213T3/da active
- 2002-04-12 DE DE60210598T patent/DE60210598T2/de not_active Expired - Fee Related
- 2002-04-12 CA CA002443470A patent/CA2443470A1/en not_active Abandoned
- 2002-12-04 UA UA2003098709A patent/UA74629C2/uk unknown
-
2003
- 2003-10-03 ZA ZA200307759A patent/ZA200307759B/en unknown
- 2003-10-08 IS IS6980A patent/IS6980A/is unknown
- 2003-10-09 NO NO20034527A patent/NO20034527L/no not_active Application Discontinuation
-
2004
- 2004-06-08 HK HK04104077A patent/HK1061026A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0208829A (pt) | Sal farmaceuticamente aceitável, composto, processos para a preparação de um sal, de um composto e de uma forma cristalina dos compostos, formulação farmacêutica, uso de um composto, e, método de profilaxia ou tratamento de uma arritmia | |
| FI900085A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi | |
| SI0937041T1 (en) | Use of a pharmaceutically acceptable salt of (3R,2'R)-3-((Cyclopently-hydroxyphenylacetyl)oxy)-1,1-dimethyl-pyrrolidinium for the preparation of a medicament | |
| ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
| AU6787690A (en) | Amino acid derivatives | |
| CA2523261A1 (en) | Fused pyrimidine derivatives with crf activity | |
| SE9904508D0 (sv) | New compounds | |
| ZA200408283B (en) | 7-aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardivascular or rental diseases | |
| FI954580A (fi) | HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon | |
| PT87866A (pt) | Processo para a preparacao de pirrolidinas e hexa-hidro-1h-azepinas substituidas por {(heterociclico biciclico) metilo e -hetero} | |
| DE69131759D1 (de) | An den Positionen 2 und 9 substituierte 4H-pyrido-(1,2-a)pyrimidin-4-one | |
| BR0315958A (pt) | Composto, composição farmacêutica, processo para a preparação de um composto, novos intermediários e uso do composto | |
| FI900084A (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsol-2-yyli- ja imidatso/4,5-b/pyridin-2-yyli-amino- ja -metyyli-1-piperidinyylietyylijohdannaisten valmistamiseksi | |
| WO2003053971A8 (en) | Pyridoquinoxaline antivirals | |
| BR0114366A (pt) | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritimia e processo para a preparação de um composto | |
| BR0208828A (pt) | Formulação farmacêutica de liberação imediata, processo para a preparação de uma formulação, composição farmacêutica sólida, processo para a formação de uma composição, uso de uma formulação, e, método de profilaxia ou tratamento de uma arritmia | |
| HUP0402282A2 (hu) | Triazolo[1,5-a]kinolin-származékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények | |
| SE0002729D0 (sv) | Novel compound form | |
| BR0208830A (pt) | Composição farmacêutica de liberação modificada, processo para a preparação de uma composição, uso de uma composição, e, método de profilaxia ou tratamento de uma arritimia | |
| WO2004089943A8 (en) | Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues | |
| SE0102057D0 (sv) | New Salts I | |
| SE9803517D0 (sv) | Pharmaceutical preparation | |
| SE0102058D0 (sv) | New Salts II | |
| EA200400877A1 (ru) | 2'-гало-3',5'-диалкоксифен-1'-илимино-2-имидазолидиновые производные и их применение для лечения недержания мочи | |
| BRPI0410020A (pt) | composto e/ou um seu sal ou estereoisÈmero farmaceuticamente aceitável, processo para preparar e uso do mesmo, composição farmacêutica, e, kit farmacêutico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010. |